JP2013520167A5 - - Google Patents

Download PDF

Info

Publication number
JP2013520167A5
JP2013520167A5 JP2012553903A JP2012553903A JP2013520167A5 JP 2013520167 A5 JP2013520167 A5 JP 2013520167A5 JP 2012553903 A JP2012553903 A JP 2012553903A JP 2012553903 A JP2012553903 A JP 2012553903A JP 2013520167 A5 JP2013520167 A5 JP 2013520167A5
Authority
JP
Japan
Prior art keywords
subject
pharmaceutical composition
immune response
administration
influenza
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2012553903A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013520167A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2011/000300 external-priority patent/WO2011102900A1/en
Publication of JP2013520167A publication Critical patent/JP2013520167A/ja
Publication of JP2013520167A5 publication Critical patent/JP2013520167A5/ja
Pending legal-status Critical Current

Links

JP2012553903A 2010-02-18 2011-02-18 万能ウイルス様粒子(vlp)インフルエンザワクチン Pending JP2013520167A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US30576810P 2010-02-18 2010-02-18
US30575910P 2010-02-18 2010-02-18
US61/305,768 2010-02-18
US61/305,759 2010-02-18
PCT/US2011/000300 WO2011102900A1 (en) 2010-02-18 2011-02-18 Universal virus-like particle (vlp) influenza vaccines

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2016131988A Division JP6524555B2 (ja) 2010-02-18 2016-07-01 万能ウイルス様粒子(vlp)インフルエンザワクチン

Publications (2)

Publication Number Publication Date
JP2013520167A JP2013520167A (ja) 2013-06-06
JP2013520167A5 true JP2013520167A5 (enExample) 2014-04-03

Family

ID=44483229

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2012553903A Pending JP2013520167A (ja) 2010-02-18 2011-02-18 万能ウイルス様粒子(vlp)インフルエンザワクチン
JP2016131988A Expired - Fee Related JP6524555B2 (ja) 2010-02-18 2016-07-01 万能ウイルス様粒子(vlp)インフルエンザワクチン

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2016131988A Expired - Fee Related JP6524555B2 (ja) 2010-02-18 2016-07-01 万能ウイルス様粒子(vlp)インフルエンザワクチン

Country Status (6)

Country Link
US (4) US9352031B2 (enExample)
EP (1) EP2536428B1 (enExample)
JP (2) JP2013520167A (enExample)
CN (1) CN102858368B (enExample)
CA (1) CA2789945A1 (enExample)
WO (1) WO2011102900A1 (enExample)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2615372A1 (en) 2007-07-13 2009-01-13 Marc-Andre D'aoust Influenza virus-like particles (vlps) comprising hemagglutinin
NZ587108A (en) 2007-11-27 2013-04-26 Medicago Inc Recombinant influenza virus-like particles (vlps) produced in transgenic plants expressing hemagglutinin
CA2789945A1 (en) * 2010-02-18 2011-08-25 Technovax, Inc. Universal virus-like particle (vlp) influenza vaccines
CN103154021A (zh) * 2010-08-16 2013-06-12 威斯特解剖及生物研究所 通用甲型流感疫苗
WO2013044203A2 (en) * 2011-09-23 2013-03-28 THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPTARTMENT OF HEALTH & HUMAN SERVICES Novel influenza hemagglutinin protein-based vaccines
US11390878B2 (en) 2011-09-30 2022-07-19 Medicago Inc. Increasing protein yield in plants
TWI700368B (zh) * 2011-09-30 2020-08-01 苜蓿股份有限公司 增加植物類病毒顆粒產率
WO2013059403A1 (en) * 2011-10-19 2013-04-25 Immunotope, Inc. Cytotoxic t-lymphocyte-inducing immunogens for prevention, treatment, and diagnosis of influenza virus infection
US9364530B2 (en) 2012-03-22 2016-06-14 Fraunhofer Usa, Inc. Virus-like particles comprising a matrix protein from a plant enveloped virus and uses thereof
US10159644B2 (en) 2012-10-26 2018-12-25 Mannkind Corporation Inhalable vaccine compositions and methods
JP2016516415A (ja) 2013-03-28 2016-06-09 メディカゴ インコーポレイテッド 植物におけるインフルエンザウイルス様粒子の生成
US12467058B2 (en) 2013-03-28 2025-11-11 Aramis Biotechnologies Inc. Influenza virus-like particle production in plants
PT3052192T (pt) * 2013-10-02 2020-09-24 Medimmune Llc Anticorpos neutralizantes anti-influenza a e suas utilizações
EP3906939A1 (en) 2013-10-11 2021-11-10 The United States of America, represented by the Secretary, Department of Health and Human Services Epstein-barr virus vaccines
WO2015101666A1 (en) 2014-01-03 2015-07-09 Fundación Biofísica Bizkaia VLPs, METHODS FOR THEIR OBTENTION AND APPLICATIONS THEREOF
EP3157557A1 (en) * 2014-06-20 2017-04-26 The U.S.A. as represented by the Secretary, Department of Health and Human Services Polyvalent influenza virus-like particles (vlps) and use as vaccines
KR102713707B1 (ko) 2014-12-31 2024-10-04 더 유나이티드 스테이츠 오브 어메리카, 애즈 리프리젠티드 바이 더 세크러테리, 디파트먼트 오브 헬쓰 앤드 휴먼 서비씨즈 신규 다가 나노입자 기반 백신
CN108348593B (zh) * 2015-08-31 2022-08-16 泰克诺瓦克斯股份有限公司 基于人呼吸道合胞病毒(hrsv)病毒样颗粒(vlps)的疫苗
KR20190056382A (ko) 2016-09-02 2019-05-24 더 유나이티드 스테이츠 오브 어메리카, 애즈 리프리젠티드 바이 더 세크러테리, 디파트먼트 오브 헬쓰 앤드 휴먼 서비씨즈 안정화된 그룹 2 인플루엔자 헤마글루티닌 줄기 영역 삼량체 및 그의 용도
MX2023012554A (es) * 2018-12-12 2023-11-08 Cambridge Tech Llc Vacuna universal contra la gripe.
CN110272473B (zh) * 2019-07-10 2021-03-02 军事科学院军事医学研究院军事兽医研究所 甲型流感通用型病毒样颗粒及其制备方法和应用
EP3896077A1 (en) * 2020-04-16 2021-10-20 Österreichische Agentur für Gesundheit und Ernährungssicherheit GmbH Influenza virus-like particles (vlps)
EP4196160A2 (en) * 2020-08-17 2023-06-21 Technovax, Inc. [sars-cov-2]-virus-like particle [vlp] vaccine: compositions, delivery strategies, methods and uses
MX2023003199A (es) * 2020-09-21 2023-04-13 Univ Georgia Vacuna contra la enfermedad por coronavirus de 2019 (covid-19) basada en el virus de la parainfluenza 5 (piv5).
CN112342149A (zh) * 2020-11-12 2021-02-09 新疆畜牧科学院兽医研究所(新疆畜牧科学院动物临床医学研究中心) 一种禽流感病毒样颗粒组装表达系统及其应用
US20250325649A1 (en) * 2021-12-31 2025-10-23 Mynvax Private Limited Polypeptide fragments, immunogenic composition against influenza virus, and implementations thereof
CN120053630B (zh) * 2025-04-28 2025-07-18 中国医学科学院医学生物学研究所 一种广谱流感疫苗的抗原表位肽组合及其应用

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1294892T3 (da) * 2000-06-23 2008-01-28 Wyeth Corp Aggregering af vildtype- og kimære influenzaviruslignende partikler (VLP'er)
US8080255B2 (en) * 2003-07-11 2011-12-20 Novavax Inc. Functional influenza virus like particles (VLPs)
US8592197B2 (en) 2003-07-11 2013-11-26 Novavax, Inc. Functional influenza virus-like particles (VLPs)
US20060051859A1 (en) * 2004-09-09 2006-03-09 Yan Fu Long acting human interferon analogs
CA2615658A1 (en) * 2005-07-19 2007-01-25 Dow Global Technolgies Inc. Recombinant flu vaccines
RU2483751C2 (ru) * 2005-10-18 2013-06-10 Новавакс, Инк. ФУНКЦИОНАЛЬНЫЕ ВИРУСОПОДОБНЫЕ ЧАСТИЦЫ ГРИППА (VLPs)
US8778353B2 (en) 2006-05-01 2014-07-15 Technovax, Inc. Influenza virus-like particle (VLP) compositions
US9101578B2 (en) 2006-05-01 2015-08-11 Technovax, Inc. Polyvalent influenza virus-like particle (VLP) compositions
AU2007345682B2 (en) * 2006-07-27 2013-07-18 Ligocyte Pharmaceuticals, Inc. Chimeric virus-like particles
US20080233150A1 (en) 2006-11-16 2008-09-25 Gale Smith Respiratory syncytial virus-virus like particle (vlps)
CN102223895B (zh) * 2008-11-25 2014-11-05 巴克斯特保健股份有限公司 生产pH稳定的包膜病毒的方法
JP2012521786A (ja) * 2009-03-30 2012-09-20 モウント シナイ スクール オフ メディシネ インフルエンザウイルスワクチン及びその使用
CA2789945A1 (en) * 2010-02-18 2011-08-25 Technovax, Inc. Universal virus-like particle (vlp) influenza vaccines
KR102072582B1 (ko) * 2012-12-31 2020-02-03 엘지전자 주식회사 듀얼 디스플레이 방법 및 장치

Similar Documents

Publication Publication Date Title
JP2013014622A5 (enExample)
JP2017509667A5 (enExample)
MX342716B (es) Vacunas para su uso en la profilaxis y tratamiento de la enfermedad del virus de influenza.
JP2015525757A5 (enExample)
JP2011105738A5 (enExample)
JP2012143233A5 (enExample)
JP2012107057A5 (enExample)
JP2014515597A5 (enExample)
JP2016535100A5 (enExample)
JP2019516735A5 (enExample)
JP2015533163A5 (enExample)
JP2015501646A5 (enExample)
JP2015518492A5 (enExample)
JP2016500312A5 (enExample)
JP2016540026A5 (enExample)
JP2015511646A5 (enExample)
JP2014507563A5 (enExample)
JP2012516348A5 (enExample)
JP2014531010A5 (enExample)
JP2014529579A5 (enExample)
JP2017014205A5 (enExample)
JP2015030781A5 (enExample)
CL2013002325A1 (es) Compuestos derivados de 4-amino-2-butenamidas, inhibidores de catepsina c; composicion farmaceutica que los comprende; procedimiento de preparacion de la composicion farmaceutica; uso del compuesto en el tratamiento de enfermedad pulmonar obstructiva cronica.
WO2016020408A3 (en) Compounds for preventing ototoxicity
HK1179177A (en) Vaccines for use in the prophylaxis and treatment of influenza virus disease